The Most Surprising Diagnostic Industry Statistics in 2024

Table of Contents

Thriving at the confluence of healthcare and technology, the diagnostic industry is a pivotal player in the modern medical arena. It serves as the backbone of clinical decision-making, enabling swift detections, effective treatments, and real-time health monitoring. However, deeply understanding the scope, trends, and potential of this industry requires a thorough exploration of its statistical landscape.

In this blog post, we will delve into the fascinating world of Diagnostic Industry Statistics, providing an enlightening tour filled with key figures, emerging trends, and potentially lucrative opportunities. Whether you’re an investor, a healthcare professional, or simply an enthusiast poised to enhance your industry knowledge, these intricate statistics will serve as your comprehensive guide to the ever-evolving diagnostic sector.

The Latest Diagnostic Industry Statistics Unveiled

The global in-vitro diagnostics market size was valued at USD 61.22 billion in 2018.

Painting the portrait of the intense breadth and depth of the diagnostic industry, our lens focuses on one captivating figure: USD 61.22 billion – the estimated value of the global in-vitro diagnostics market in 2018. This monumental figure does not stand alone, but narrates the story of booming growth, extensive research, and technologic advancements within the sector.

This significant value encapsulates the surging demand for precision diagnosis, control of potential diseases and prevention of detrimental health risks, making it a lighthouse statistic guiding the course of our deep dive into the world of diagnostic industry statistics.

The global diagnostic imaging market is expected to reach USD 33.3 billion by 2024 from USD 25.9 billion in 2019, at a CAGR of 5.2%.

Shining a spotlight on this impressive growth trajectory, the projection that the global diagnostic imaging market could swell to USD 33.3 billion by 2024 from USD 25.9 billion in 2019 offers an exhilarating glimpse into the future of the diagnostic industry. This forecast, boasting a robust CAGR of 5.2%, is not just a number. It’s an indication of the growing demand for advanced diagnostic solutions, promising a leap in the capabilities and reach of the industry.

As such, it signals a ripe investment opportunity, underscored by a promising growth potential. It’s an encouraging nudge for entrepreneurs and innovators to fiercely participate in this sector, inspired by its lucrative prospects. Furthermore, this statistic exemplifies the rising global focus on healthcare and disease detection. It’s not just a forecast, it’s a testament to the world’s dedication to healthier futures and advanced medical solutions, which is a crucial perspective for any discussion around diagnostic industry statistics.

The molecular diagnostics market is projected to reach $31.8 billion by 2026 from $17.8 billion in 2021, at a CAGR of 12.3% during the forecast period.

Showcasing the expected growth in the molecular diagnostics market directly highlights the sector’s rapidly increasing influence within the diagnostic industry. The projection from $17.8 billion in 2021 to $31.8 billion by 2026 at a CAGR of 12.3% unveils the tremendous expansion pace that this particular market segment is set to experience.

This engrossing numeric revelation not only underscores the promising financial potential of investments in the area, but also hints at the amplified usage and demand for molecular diagnostic techniques within healthcare settings. Consequently, it becomes a spotlight in our blog post, informing readers about the flourishing opportunities and evolving trends in the ever-dynamic landscape of the diagnostic industry.

The global point of care diagnostics market is expected to grow at a CAGR of 10.4% from 2020 to 2027 to reach $46.7 billion by 2027.

Highlighting the robust projected growth of the global point of care diagnostics market sets a powerful stage for the blog post. It underscores the increasing dynamics and significant potential this industry holds. With an anticipated 10.4% compound annual growth rate (CAGR) from 2020 to 2027, reaching $46.7 billion by 2027, the statistic establishes a sense of urgency and excitement about the industry’s developments.

This isn’t just a story of steady growth; it’s a dramatic narrative of a thriving industry rapidly evolving to meet ever-changing global needs. This bold projection is indicative of shifts in health care delivery models, technological advancements, and the rising demand for quick and accurate diagnostic tools. So, as we delve into the depths of Diagnostic Industry statistics, let this projection serve as our guiding star, illuminating the path of progression in this vastly important industry.

Digital pathology market size was valued at USD 743.4 million in 2020 in the U.S.

Immersing ourselves into the nuances of diagnostic industry statistics, the revelation of the digital pathology market size reaching a remarkable value of USD 743.4 million in 2020 significantly elevates our understanding of the industry’s landscape. This figure, not merely a number, but an emblem of progression, illustrates the mounting reliance and faith in digital pathology solutions in the U.S.

It acts as a spotlight casting its focused beam on the growing necessity, adoption, and importance of digitization in the healthcare sector, specifically the pathology industry. Moreover, it provides valuable insight into the market potential, industry trends, and the futuristic direction of the medical diagnostics sector. And most crucially, the impressive figure enhances our appreciation of how technology is rewriting the rules and scale of diagnostic opportunities available for the providers and seekers of healthcare alike.

The global cancer diagnostics market size was valued at USD 144.4 billion in 2018.

Peering into the vast landscape of the diagnostic industry, an arresting figure leaps forward, the resounding echo of USD 144.4 billion. This hefty sum, representative of the global cancer diagnostics market size in 2018, opens a window into the colossal scale and immense impact the sector bears. It signals the presence of both massive financial backing and substantial demand, painting an increasingly important picture of the relevance of diagnostics in global healthcare.

In the frame of a blog post about Diagnostic Industry Statistics, this figure elegantly illuminates the enormous strides in cancer detection innovation and the critical intersection of health imperatives with technology. For investors and professionals in the industry, it offers an encapsulated snapshot of market potential, while for patients and healthcare providers, it is a testament to the resources and attention being funneled towards the war on cancer. This reflection of the market’s magnitude essentially underlines the colossal weight the diagnostic industry harbors in the modern health landscape.

The global Prenatal Testing and Newborn Screening market size is projected to reach US$ 8609.1 million by 2027, from US$ 4941.9 million in 2020.

The meteoric rise in the value of the global Prenatal Testing and Newborn Screening market, expected to almost double from US$ 4941.9 million in 2020 to a remarkable US$ 8609.1 million by 2027, reveals an incredibly potent growth trajectory. This market growth is a testament to the increasing demand for early detection of health anomalies in newborns, signifying a highly significant shift in the healthcare diagnostic industry.

In addition, this projected surge underlines a robust investment capability in the sector, indicating diagnostic players’ potential for expansive growth, innovation and the transformation of healthcare solutions on an unprecedented scale. It subsequently illuminates a noteworthy opportunity for stakeholders in the diagnostic industry to capitalize and innovate within this fast-evolving arena.

The global IVD quality control market is projected to reach USD 1.2 billion by 2025 from USD 961 million in 2020, at a CAGR of 5.2% during the forecast period.

Unveiling the forthcoming boom in the global IVD quality control market, it is intriguing to note that its value is expected to blossom from USD 961 million in 2020 to a staggering USD 1.2 billion by 2025. This growth trajectory, pulsating at a compound annual growth rate of 5.2% throughout the projection period, paints an optimistic picture of the robust health of the diagnostic industry.

Such weighty numbers are not just digits on paper, they shine light on a burgeoning segment of diagnostic industry, galvanizing further investment and innovation. The steep trajectory underscores the amplified importance of quality control in In Vitro Diagnostics (IVD), thereby highlighting enhanced focus on precision and accuracy in diagnosis – a significant step forward in improving healthcare standards globally.

Moreover, this uptick is an empirical signal of the industry’s resilience and growth potential amidst global challenges. So for anyone seeking comprehensive insights about the Diagnostic Industry, this extrapolation serves as a testament to the industry’s unfaltering momentum, marking an era of robust growth.

The diagnostic specialty antibodies market is projected to reach $40.6 billion by 2025, growing at a CAGR of 6.6% during 2018-2025.

Charting the trajectory of the diagnostic specialty antibodies market, we’re witnessing the unfolding of a remarkable economic phenomenon. As it’s poised to skyrocket to $40.6 billion by 2025, pulsing at a robust CAGR of 6.6% from 2018 to 2025, this statistic is a North Star in the financial firmament of the Diagnostic Industry Statistics. It’s not just a number, but an Atlas holding up the sky of potential growth, indicating the sheer magnitude and pace of expansion within this market.

It highlights a compound mix of an escalating global demand for advanced diagnostic procedures, and the industry’s stride to meet that demand. In the grand narrative of the Diagnostic Industry, this figure paints a picture of inspiration and aspiration, where the structural, strategic, and technological canvas of the diagnostic specialty antibodies market witnesses continuous innovation and progression.

In a blog post covering Diagnostic Industry Statistics, such a revelation mightily upholds the potential investment opportunities, future projections, and growth forecast, meticulously providing a snapshot of the expected dynamism that is about to unfold in the near future. Providing this statistic in such context, will evoke a vision of an industry that is evolving at a significant pace and is daringly moving towards future complexities.

The global diagnostics market witnessed 5% year-on-year growth in 2017.

In dissecting the core of this intriguing figure – the 5% year-on-year global diagnostics market growth in 2017, you cannot overlook its significance in the larger landscape of Diagnostic Industry Statistics. On its own, it may appear as a simple statistic, but beneath the surface, it’s a powerful indicator of the sector’s dynamic strength and current trajectory.

A 5% annual growth is an impressive pace, showcasing the robust and vibrant nature of the diagnostics industry on a global scale. It’s a pivotal insight for stakeholders, indicating expanding demand and the potential for increased profitability.

Not only does it underline the industry’s sustained development—it also illuminates opportunities for investment, areas for innovation, and the potential for public and private sector collaboration. It creates a distinctive pulse on the health of the diagnostic industry, offering a measurable barometer for industry stakeholders to assess the viability of their strategies and investments.

In essence, that 5% year-on-year growth in 2017 isn’t merely a statistic—it’s a revelation, a testament to the global diagnostics industry’s heartening resilience and promising future.

The diagnostic imaging services market size was valued at $578.5 billion in 2021.

Expanding on the radiant heat of the statistic, we shed light on the diagnostic imaging services market size’s heft, valued at $578.5 billion in 2021. It’s a testament to the consuming growth and enormity of the industry, evoking the image of a titan. This statistic encapsulates the industry’s gravitational pull on the healthcare sector, capturing the intense investment and faith firms are placing in these services.

The numbers are louder than words, reflecting the resonance of a thriving hub for research, innovation, and application, especially in the epoch of COVID-19 that demands a higher echelon of diagnostic tools and services. Undeniably, this data point anchors the fierce energy, the pulsating heartbeat of the industry’s current landscape, proving to be a vital graph line in the narrating saga of the diagnostic industry.

MicroRNA diagnostics and therapeutics market size was valued at USD 144 million in 2016 globally.

Unveiling the colossal value of microRNA diagnostics and therapeutic market highlights an intriguing shift in the diagnostic industry landscape. As per global data, it was a whopping USD 144 million strong in 2016. This cool statistic isn’t just a number with multiple zeroes to wow the readers. On the contrary, it underscores the economic heft and evolving influence of this advanced diagnostic solution in the healthcare sector.

It’s a number that represents the rising investment and rapid innovation encapsulating this field. Hence, while talking about the Diagnostic Industry Statistics, it’s a figure that punctuates the narrative, introducing the readers to the bustling opportunities and room for growth that this particular market segment posits.

The global molecular diagnostics point of care market to grow from $2.28 billion in 2019 to $10.50 billion by 2030, at a CAGR of around 14%.

The surge of the global molecular diagnostics point of care market from a sizeable $2.28 billion in 2019 to an impressive $10.50 billion by 2030 epitomizes the expanding horizon of the diagnostics industry. The staggering compound annual growth rate of roughly 14% truly reflects the brisk pace at which diagnostic technology is progressing. When confronting this statistic in a blog about Diagnostic Industry Statistics, it’s evident that the molecular diagnostics market isn’t just evolving, it’s revolutionizing healthcare.

Accompanying computation and precision, the industry promises to deliver prompt results, hence transforming patient care and medical decisions worldwide. This statistics, hence, serves as a harbinger of the transformations, compelling readers to stay tuned to the unfolding narrative of the diagnostics industry progression.

The Asia Pacific in-vitro diagnostics market size was valued at USD 16.5 billion in 2019.

In the terrain of global diagnostic industry statistics, the remarkable valuation of the Asia Pacific in-vitro diagnostics market at USD 16.5 billion in 2019 emerges as a compelling indicator of potential growth. It gives the market a noteworthy position, underscoring the influence of the Asia-Pacific region on the global scale.

This figure sets a fascinating precedent, demonstrating the market’s ability to generate strong economic impact and signalling potential for richer gains in the coming years. It is a clear reflection of the region’s drive and capacity to leverage advancements in health technology, enriching our understanding of the in-vitro diagnostics landscape.

The diagnostic enzymes market is expected to register a CAGR of 5.9% during the period, 2021-2028.

Shining a light on the diagnostic enzymes market and its predicted growth pathway can provide a robust foundation for understanding the trajectory of the diagnostic industry. Nestled within this promising forecast of a 5.9% CAGR for the duration of 2021-2028, are key insights into the vitality of diagnostic enzymes which are widely used in disease diagnosis and drug testing.

Such compelling growth rates and potential market development envisage impressive returns for key players in the sector, and offer a beacon of opportunity for potential investors. Moreover, it serves as a testament to the increasing reliance on diagnostic enzymes in various clinical settings – a trend that reflects the evolving dynamics of the diagnostic industry.

The global market for clinical diagnostics is projected to reach $82.8 billion by 2026.

Unveiling this dynamic prognosis in the realm of Diagnostic Industry Statistics, the formidable prediction that the global market for clinical diagnostics is anticipated to skyrocket to $82.8 billion by 2026 casts a promising light on the sector’s future. This astronomical figure tells us a compelling story of the industry’s growth potential, promising robustness and financial success, and thus serves as substantial proof of the industry’s upward trajectory.

By underpinning this blog post, it signals to investors and stakeholders alike that the diagnostic industry is thriving and poised for significant expansion in the coming years. Thus, it becomes an indispensable touchstone to understand the future turf of global healthcare, establishing the anticipated economic significance and prosperity of the diagnostic industry.

The companion diagnostics market is projected to reach $9.9 billion by 2026, at a CAGR of 12.6% during the forecast period.

Highlighting such a potent statistic, one can decipher the monumental growth trajectory of the companion diagnostics market. Through the impressive number of $9.9 billion by 2026, we draw an image of an industry filled with immense potential—coupled with a compound annual growth rate (CAGR) of 12.6%, a vision of a rocketing pace of expansion emerges.

Further, this statistical estimate provides a beautiful blend of future prediction and present growth rates, making it a perfect reference point for gauging the health and prospects of the diagnostic industry in general. It becomes a cornerstone to stand on when dissecting industry trends, investment strategies, market shares and opportunity regions. When positioned in a blog post about Diagnostic Industry Statistics, it serves as a powerful, compact synopsis, describing an industry in the midst of a giant leap forward.

The global diagnostic ultrasound market size is expected to reach USD 8.5 billion by 2026.

In the sweeping panorama of Diagnostic Industry Statistics, the projected growth of the global diagnostic ultrasound market demands a spotlight. Poised to scale towering heights of USD 8.5 billion by 2026, it paints an astounding picture of opportunities in the realm of healthcare diagnostics.

This numerical beacon not only highlights the ocean of potential within the ultrasound diagnostic sector but also signals a era of unprecedented market growth. Hold onto this statistical postcard, because it is both a narrative of fortune’s favor and a compass pointing to where windfalls await in the expanding territory of medical diagnoses.

The global autoimmune disease diagnostics market size is expected to reach USD 6.3 billion by 2025.

Projecting the global autoimmune disease diagnostics market to hit a staggering value of USD 6.3 billion by 2025 reflects a monumental leap that carries profound implications for the diagnostic industry. Driven by growing rates of autoimmune disorders and rapid advances in diagnostic technology, these figures offer not only a testament to the scale and potential of the market, but also an invaluable insight into disease prevalence, research investments, and healthcare priorities.

In a blog post dissecting Diagnostic Industry Statistics, such analysis opens a porthole, offering readers a glimpse into the macroscopic dynamics at play, and allows for profound understanding of the market’s trajectory, challenges, and opportunities.

The global market for early detection and diagnostic tests is projected to reach USD 40.5 billion by 2025.

This revelation not only excites those with an interest in the diagnostic industry, but also paints an inspiring and optimistic picture of where the market is heading by 2025. The projection of a USD 40.5 billion worth pinpoints an enormous growth potential and investment opportunities in the sector of early detection and diagnostic tests.

The promising trajectory for this spike illuminates the increasing global awareness and emphasis laid on early detection of diseases for a healthier lifestyle. Therefore, in a blog post focusing on Diagnostic Industry Statistics, this figure serves as a powerful beacon of progress, and underscores the colossal strides being made in this arena.


In summary, the diagnostic industry plays a critical role in healthcare, driving innovative approaches to disease detection and health management. The impressive statistics reflect this sector’s dynamic growth, highly influenced by advancements in technology, increased healthcare spending, and the ongoing global health challenges. Keeping an eye on these defining trends and statistics is crucial for stakeholders aiming to stay at the forefront of this rapidly evolving industry.

With the current trajectory, the diagnostic industry promises to grow even further, offering immense potential for companies and investors alike. As we move forward, awareness and understanding of diagnostic industry statistics will be key to leveraging opportunities and driving strategic decisions for growth and profitability.


0. –

1. –

2. –

3. –

4. –

5. –

6. –

7. –

8. –

9. –

10. –

11. –


What is the Diagnostic Industry?

The Diagnostic Industry involves companies that manufacture and distribute diagnostic imaging systems, clinical laboratory equipment, and other medical tools used to detect diseases, evaluate patient health conditions, and monitor treatment progress.

What are the main sectors in the Diagnostic Industry?

The main sectors in the Diagnostic Industry typically include in-vitro diagnostics (-tests carried out in a controlled environment), diagnostic imaging (like MRI and ultrasound), point-of-care diagnostics (tests done at or near the patient's location), and tissue diagnostics (analysis of tissue samples).

What are the growth prospects of the Diagnostic Industry?

The Diagnostic Industry is expected to see significant growth in the coming years. This growth is driven by several factors such as the rising prevalence of chronic diseases, an increase in the geriatric population, technological advancements, and increased healthcare expenditure and infrastructure in developing countries.

What are the key challenges faced by companies in the Diagnostic Industry?

Key challenges in the Diagnostic Industry include regulatory hurdles, technological advancements, and competition from other companies. Plus, establishing the clinical validity and utility of diagnostic tests, especially in developing countries, poses another challenge.

How has COVID-19 affected the Diagnostic Industry?

The COVID-19 pandemic has significantly impacted the Diagnostic Industry. The urgent need for rapid and accurate testing has led to the chronic development of diagnostic tests, thus boosting the industry's growth. However, it also faced challenges like supply chain disruptions and increased workload.

How we write our statistic reports:

We have not conducted any studies ourselves. Our article provides a summary of all the statistics and studies available at the time of writing. We are solely presenting a summary, not expressing our own opinion. We have collected all statistics within our internal database. In some cases, we use Artificial Intelligence for formulating the statistics. The articles are updated regularly.

See our Editorial Process.

Table of Contents

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!